The Discounted Cash Flow (DCF) valuation of Celltrion Pharm Inc (068760.KQ) is 37,164.38 KRW. With the latest stock price at 54,400.00 KRW, the upside of Celltrion Pharm Inc based on DCF is -31.7%.
Based on the latest price of 54,400.00 KRW and our DCF valuation, Celltrion Pharm Inc (068760.KQ) is a sell. selling 068760.KQ stocks now will result in a potential gain of 31.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.8% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 22,963.52 - 86,553.56 | 37,164.38 |
| Upside | -57.8% - 59.1% | -31.7% |